Agios Pharm Cash Flow Quality Index
Agios Pharm cash flow quality index. Agios Pharm (AGIO) has a Cash Flow Quality Index of -0.09x as of September 2024. Operating cash flow of $-84.22 Million is below net income of $947.91 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore AGIO debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Agios Pharm (2024–2024)
Cash flow quality index of Agios Pharm from 2024 to 2024. Historical Cash Flow Quality Index for Agios Pharm across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. See AGIO equity to assets ratio to measure how much of total assets are equity-financed.
Agios Pharm Cash Flow Quality Index by Year (2024–2024)
Agios Pharm cash flow quality index by year from 2024 to 2024. Year-by-year earnings quality comparison for Agios Pharm. For the full cash flow conversion analysis, see AGIO operating cash flow.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.58x | $-389.84 Million | $673.73 Million | — |